In8bio annual operating expenses
2020
2021
2022
2023
2024
2025
In8bio Operating Expenses Growth & History (INAB)
In8bio's operating expenses was $19.9M for fiscal 2025.
View full In8bio company overviewIn8bio annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $19.9M | −$10.8M | −35.24% |
| 2024 | 2024-12-31 | $30.7M | $330,000 | +1.09% |
| 2023 | 2023-12-31 | $30.3M | $1.8M | +6.37% |
| 2022 | 2022-12-31 | $28.5M | $13.9M | +94.64% |
| 2021 | 2021-12-31 | $14.7M | $6.1M | +71.24% |
| 2020 | 2020-12-31 | $8.6M | — | — |
In8bio quarterly operating expenses
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.9M | −$266,000 | −5.11% |
| Q1 2026 | 2026-03-31 | $5.3M | −$394,000 | −6.96% |
| Q4 2025 | 2025-12-31 | $5.0M | −$1.2M | −19.14% |
| Q3 2025 | 2025-09-30 | $4.0M | −$3.1M | −44.20% |
| Q2 2025 | 2025-06-30 | $5.2M | −$3.5M | −40.14% |
| Q1 2025 | 2025-03-31 | $5.7M | −$3.0M | −34.53% |
| Q4 2024 | 2024-12-31 | $6.2M | −$1.4M | −18.08% |
| Q3 2024 | 2024-09-30 | $7.1M | −$60,000 | −0.84% |
| Q2 2024 | 2024-06-30 | $8.7M | $974,000 | +12.62% |
| Q1 2024 | 2024-03-31 | $8.6M | $790,000 | +10.06% |
| Q4 2023 | 2023-12-31 | $7.6M | −$200,000 | −2.56% |
| Q3 2023 | 2023-09-30 | $7.2M | −$230,000 | −3.11% |
| Q2 2023 | 2023-06-30 | $7.7M | $536,000 | +7.47% |
| Q1 2023 | 2023-03-31 | $7.9M | $1.7M | +27.83% |
| Q4 2022 | 2022-12-31 | $7.8M | $1.9M | +33.32% |
| Q3 2022 | 2022-09-30 | $7.4M | $4.0M | +118.20% |
| Q2 2022 | 2022-06-30 | $7.2M | $4.1M | +135.38% |
| Q1 2022 | 2022-03-31 | $6.1M | $3.8M | +160.05% |
| Q4 2021 | 2021-12-31 | $5.8M | — | — |
| Q3 2021 | 2021-09-30 | $3.4M | $1.7M | +101.73% |
| Q2 2021 | 2021-06-30 | $3.0M | $176,000 | +6.12% |
| Q1 2021 | 2021-03-31 | $2.4M | — | — |
| Q3 2020 | 2020-09-30 | $1.7M | — | — |
| Q2 2020 | 2020-06-30 | $2.9M | — | — |
In8bio operating expenses trends
Over the last five fiscal years, In8bio's operating expenses increased from $8.6M to $19.9M, a change of $11.3M. The latest reported quarter, Q2 2026, shows $4.9M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review In8bio source filings ↗